PubRank

M E Thase

Author PubWeight™ 159.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000 10.25
2 Whole-genome association study of bipolar disorder. Mol Psychiatry 2008 6.80
3 The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997 6.32
4 Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA 2001 5.37
5 Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 1998 4.48
6 Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001 4.34
7 Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999 4.22
8 The role of psychotherapy in the treatment of depression: review of two practice guidelines. Arch Gen Psychiatry 1996 3.95
9 Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000 2.70
10 Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990 2.66
11 General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand 2013 2.14
12 The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 1998 2.13
13 Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence. J Consult Clin Psychol 1998 2.01
14 Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry 2001 1.88
15 The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry 1999 1.84
16 The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods. Arch Gen Psychiatry 1997 1.56
17 Gender differences in chronic major and double depression. J Affect Disord 2000 1.53
18 Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997 1.52
19 Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment. Biol Psychiatry 2001 1.52
20 Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse. Am J Psychiatry 1996 1.45
21 Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord 1999 1.45
22 Primary care patients' personal illness models for depression: a preliminary investigation. Fam Pract 2001 1.44
23 Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 1997 1.44
24 Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001 1.42
25 Therapeutic alliance as a predictor of outcome and retention in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. J Consult Clin Psychol 2001 1.41
26 Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2000 1.38
27 Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992 1.38
28 Validation of a Hamilton subscale for endogenomorphic depression. J Affect Disord 1983 1.33
29 Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psychiatry 1999 1.33
30 Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med 2012 1.26
31 Assessment of sexual function in depressed, impotent, and healthy men: factor analysis of a Brief Sexual Function Questionnaire for men. Psychiatry Res 1988 1.25
32 Lost human capital from early-onset chronic depression. Am J Psychiatry 2000 1.25
33 Disproportionate suicidality in patients with comorbid major depression and alcoholism. Am J Psychiatry 1995 1.24
34 Bipolar depression: an underestimated treatment challenge. Depress Anxiety 1997 1.21
35 Longevity and mortality in Down's syndrome. J Ment Defic Res 1982 1.17
36 A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand 2009 1.08
37 Natural history and preventative treatment of recurrent mood disorders. Annu Rev Med 1999 1.05
38 Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study. Am J Psychiatry 1998 1.05
39 Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Neuropsychopharmacology 1999 1.05
40 The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry 1998 1.05
41 Which depressive symptoms are related to which sleep electroencephalographic variables? Biol Psychiatry 1997 1.04
42 Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test. Am J Psychiatry 1991 1.03
43 Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients. Am J Psychiatry 1996 1.03
44 Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav 1999 1.03
45 Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999 1.03
46 Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991 0.99
47 Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction. J Abnorm Psychol 2000 0.99
48 Gender differences in presentation of chronic major depression. Psychopharmacol Bull 1995 0.98
49 Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 1993 0.98
50 Patterns of suicidality and alcohol use in alcoholics with major depression. Alcohol Clin Exp Res 1996 0.97
51 Prefrontal and cerebellar abnormalities in major depression: evidence from oculomotor studies. Biol Psychiatry 1998 0.97
52 Cognition and life stress in depression: cognitive factors and the definition, rating, and generation of negative life events. J Abnorm Psychol 1993 0.96
53 Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients. Biol Psychiatry 1999 0.96
54 REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 1995 0.96
55 Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry 1998 0.96
56 Toward an integration of psychologic, social, and biologic factors in depression: effects on outcome and course of cognitive therapy. J Consult Clin Psychol 1995 0.95
57 Age-related neuropsychological deficits in Down's syndrome. Biol Psychiatry 1984 0.94
58 Gender effects on the clinical presentation of alcoholics at a psychiatric hospital. Compr Psychiatry 1996 0.94
59 Fenfluramine challenge test as a predictor of outcome in major depression. Psychopharmacol Bull 1993 0.93
60 Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord 2001 0.92
61 Anger attacks: correlates and significance of an underrecognized symptom. J Clin Psychiatry 1999 0.91
62 Identifying "paradigm failures" contributing to treatment-resistant depression. J Affect Disord 2005 0.91
63 The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry 1998 0.90
64 Sleep, gender, and depression: an analysis of gender effects on the electroencephalographic sleep of 302 depressed outpatients. Biol Psychiatry 1990 0.89
65 Impact of psychosocial treatments on associated problems of cocaine-dependent patients. J Consult Clin Psychol 2001 0.88
66 Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci Ther 2011 0.88
67 Life stress and the symptoms of major depression. J Nerv Ment Dis 2001 0.86
68 Naltrexone utility in depressed alcoholics. Psychopharmacol Bull 1998 0.86
69 A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy. J Affect Disord 1997 0.86
70 Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. Psychol Med 2003 0.86
71 Medication adherence in a comparative effectiveness trial for bipolar disorder. Acta Psychiatr Scand 2013 0.86
72 Reversible dementia in Down's syndrome. J Ment Defic Res 1982 0.85
73 Clinical evaluation of dementia in Down's syndrome: a preliminary report. J Ment Defic Res 1982 0.85
74 Bipolar disorder therapeutics: maintenance treatment. Biol Psychiatry 2000 0.84
75 The clinical, psychosocial, and pharmacoeconomic ramifications of remission. Am J Manag Care 2001 0.84
76 Cocaine use associated with increased suicidal behavior in depressed alcoholics. Addict Behav 1998 0.84
77 Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacol Bull 1998 0.83
78 Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol 1999 0.83
79 Electroencephalographic sleep in psychotic depression. A valid subtype? Arch Gen Psychiatry 1986 0.83
80 Patterns of attrition for psychosocial and pharmacologic treatments of depression. J Clin Psychiatry 1985 0.83
81 Symptomatic volunteers in depression research: a closer look. Psychiatry Res 1984 0.82
82 Racial effects on the clinical presentation of alcoholics at a psychiatric hospital. Compr Psychiatry 1996 0.82
83 Low rate of membrane lithium transport during treatment correlates with outcome of maintenance pharmacotherapy in bipolar disorder. Neuropsychopharmacology 1997 0.82
84 Risperidone: review of its therapeutic utility in depression. Psychopharmacol Bull 2001 0.82
85 Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Psychol Med 2009 0.81
86 Stimulation of cell membrane sodium transport activity by lithium: possible relationship to therapeutic action. Psychiatry Res 1987 0.81
87 Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive-behavioral therapy. J Consult Clin Psychol 1994 0.81
88 Rhabdomyolysis complicating rapid intramuscular neuroleptization. J Clin Psychopharmacol 1984 0.81
89 Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients. J Clin Psychopharmacol 1999 0.81
90 The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients. Psychopharmacol Bull 1995 0.80
91 Strategies and tactics in the treatment of chronic depression. J Clin Psychiatry 1997 0.80
92 Cognitive therapy with inpatients. Gen Hosp Psychiatry 1997 0.80
93 Response to cognitive-behavioral therapy in depression: effects of pretreatment cognitive dysfunction and life stress. J Consult Clin Psychol 1997 0.79
94 A comprehensive review of cyclothymic disorder. J Nerv Ment Dis 1993 0.79
95 Urinary free cortisol levels among depressed men and women: differential relationships to age and symptom severity? Arch Womens Ment Health 2007 0.79
96 Basal ganglia calcification and psychosis in Down's syndrome. Postgrad Med J 1984 0.79
97 Are personality assessments valid in acute major depression? J Affect Disord 1992 0.79
98 Gender-specific response to depression treatment. J Gend Specif Med 2001 0.79
99 Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: electroencephalographic sleep studies and response to cognitive therapy. J Consult Clin Psychol 1992 0.79
100 Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression. Psychopharmacol Bull 1992 0.79
101 Biological studies of dysthymia. Biol Psychiatry 1991 0.79
102 The undertreatment of dysthymia. J Clin Psychiatry 1997 0.79
103 Social factors and the psychobiology of depression: relations between life stress and rapid eye movement sleep latency. J Abnorm Psychol 1992 0.79
104 Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using. Psychiatry Res 2001 0.78
105 Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions. J Clin Psychopharmacol 1990 0.78
106 The use of the sleep laboratory in the diagnosis of affective disorders. Psychiatr Clin North Am 1983 0.78
107 Gender differences in cognitive diathesis-stress domain match: implications for differential pathways to depression. J Abnorm Psychol 1996 0.78
108 Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 2000 0.77
109 Electroencephalographic sleep in secondary depression: a revisit. Biol Psychiatry 1984 0.77
110 Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study. Addict Behav 2000 0.77
111 Onset of depression and time to treatment entry: roles of life stress. J Consult Clin Psychol 1991 0.77
112 Sexual function in depressed men. Assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy. Arch Gen Psychiatry 1993 0.77
113 Variability of erythrocyte and serum lithium levels correlates with therapist treatment adherence efforts and maintenance treatment outcome. Neuropsychopharmacology 2001 0.77
114 Double-blind fluoxetine in depressed alcoholic smokers. Psychopharmacol Bull 1997 0.77
115 Assessment of sexual function, interest and activity in depressed men. J Affect Disord 1987 0.77
116 Shifts in affective balance during cognitive therapy of major depression. J Consult Clin Psychol 1992 0.77
117 The balance of positive and negative affects in major depression: a further test of the States of Mind model. Psychiatry Res 1991 0.76
118 Correlation of nocturnal penile tumescence and daytime affect intensity in depressed men. Psychiatry Res 1993 0.75
119 Psychotherapies in residency training. J Psychother Pract Res 1999 0.75
120 Manic pseudodementia. Psychosomatics 1984 0.75
121 Update on the management of bipolar illness. J Clin Psychiatry 1998 0.75
122 The click-murmur syndrome and anxiety disorder. JAMA 1981 0.75
123 Suicides in jails and prisons. J Psychosoc Nurs Ment Health Serv 1983 0.75
124 Inpatient applications of cognitive-behavioral therapy : a review of recent developments. J Psychother Pract Res 1994 0.75
125 Nocturnal penile tumescence in healthy 20- to 59-year-olds: a revisit. Sleep 1989 0.75
126 Evaluation of depression in a general hospital: utility and limitations of the dexamethasone suppression test. Gen Hosp Psychiatry 1985 0.75
127 Evaluating the hopelessness model of depression: diathesis-stress and symptom components. J Abnorm Psychol 1993 0.75
128 A Hamilton subscale for endogenomorphic depression. Hillside J Clin Psychiatry 1984 0.75
129 Treatment outcome for solicited versus nonsolicited unipolar depressed female outpatients. J Consult Clin Psychol 1984 0.75
130 Clinical characteristics associated with interpersonal depression: symptoms, course and treatment response. J Affect Disord 1994 0.75
131 Antiarrhythmic effects of tricyclic antidepressants. JAMA 1982 0.75
132 Diagnostic certainty of a voluntary bipolar disorder case registry. J Affect Disord 1999 0.75
133 The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity. Biol Psychiatry 1993 0.75
134 Are buckling force measurements reliable in nocturnal penile tumescence studies? Sleep 1993 0.75
135 Does early intervention increase latency to relapse in major depressive disorder? Re-evaluation with cognitive behavior therapy. J Affect Disord 2002 0.75
136 Characterizing organic mood syndrome, manic type. Compr Psychiatry 1995 0.75
137 Comparison of cognitive models of depression: relationships between cognitive constructs and cognitive diathesis-stress match. J Abnorm Psychol 1997 0.75
138 Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials. J Affect Disord 2013 0.75
139 Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in nonresponders and responders. Curr Med Res Opin 2011 0.75
140 Dexamethasone suppression test in depression. Pa Med 1984 0.75
141 Psychobiological markers in secondary depression. Am J Psychiatry 1983 0.75
142 Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacol Bull 1993 0.75
143 Results of nocturnal penile tumescence studies are abnormal in sexually functional diabetic men. Arch Intern Med 1992 0.75
144 Normal beard growth and testicular volume in depressed men. Arch Gen Psychiatry 1989 0.75
145 Switching strategies for the treatment of unipolar major depression. Mod Probl Pharmacopsychiatry 1997 0.75
146 Reduced cell membrane affinity for lithium ion during maintenance treatment of bipolar affective disorder. Biol Psychiatry 1990 0.75
147 Nocturnal penile tumescence in depressed men. Am J Psychiatry 1987 0.75
148 Response to placebo among bipolar I disorder patients experiencing their first manic episode. Bipolar Disord 2000 0.75
149 Life events and the endogenous-nonendogenous distinction in the treatment and posttreatment course of depression. Compr Psychiatry 1985 0.75
150 Social skills training and endogenous depression. J Behav Ther Exp Psychiatry 1984 0.75